Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial
Titel:
Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial
Auteur:
Greil, Richard Obrtlíková, Petra Smolej, Lukáš Kozák, Tomáš Steurer, Michael Andel, Johannes Burgstaller, Sonja Mikušková, Eva Gercheva, Liana Nösslinger, Thomas Papajík, Tomáš Ladická, Miriam Girschikofsky, Michael Hrubiško, Mikuláš Jäger, Ulrich Fridrik, Michael Pecherstorfer, Martin Králiková, Eva Burcoveanu, Cristina Spasov, Emil Petzer, Andreas Mihaylov, Georgi Raynov, Julian Oexle, Horst Zabernigg, August Flochová, Emília Palášthy, Stanislav Stehlíková, Olga Doubek, Michael Altenhofer, Petra Pleyer, Lisa Melchardt, Thomas Klingler, Anton Mayer, Jiří Egle, Alexander